BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16273224)

  • 1. Epithelial-mesenchymal transition in gastric cancer (Review).
    Katoh M
    Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF signaling network in the gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular requirements for epithelial-mesenchymal transition during tumor progression.
    Huber MA; Kraut N; Beug H
    Curr Opin Cell Biol; 2005 Oct; 17(5):548-58. PubMed ID: 16098727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
    Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review).
    Katoh Y; Katoh M
    Int J Mol Med; 2008 Sep; 22(3):271-5. PubMed ID: 18698484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
    Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
    Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
    Humar B; Guilford P
    Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
    Billottet C; Tuefferd M; Gentien D; Rapinat A; Thiery JP; Broët P; Jouanneau J
    J Cell Biochem; 2008 Jun; 104(3):826-39. PubMed ID: 18189245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.
    Moustakas A; Heldin CH
    Cancer Sci; 2007 Oct; 98(10):1512-20. PubMed ID: 17645776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDH1 associated gastric cancer: a report of a family and review of the literature.
    Moran CJ; Joyce M; McAnena OJ
    Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions.
    Vandewalle C; Comijn J; De Craene B; Vermassen P; Bruyneel E; Andersen H; Tulchinsky E; Van Roy F; Berx G
    Nucleic Acids Res; 2005; 33(20):6566-78. PubMed ID: 16314317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
    Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.